Get the Stockscreener App
8.55
5.00%
-0.45
Sensei Biotherapeutics Inc stock is traded at $8.55, with a volume of 22,428.
It is down -5.00% in the last 24 hours and down -15.35% over the past month.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
See More
Previous Close:
$9.00
Open:
$8.61
24h Volume:
22,428
Relative Volume:
0.44
Market Cap:
$10.78M
Revenue:
-
Net Income/Loss:
$-29.80M
P/E Ratio:
-7.1849
EPS:
-1.19
Net Cash Flow:
$-25.19M
1W Performance:
-12.04%
1M Performance:
-15.35%
6M Performance:
+27.42%
1Y Performance:
-0.60%
1-Day Range:
$8.55
$9.15
1-Week Range:
$7.57
$9.23
52-Week Range:
$5.00
$18.35
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Name
Sensei Biotherapeutics Inc
Sector
Industry
Phone
(240) 243-8000
Address
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Compare SNSE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
8.55 | 11.35M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-01-21 | Downgrade | Berenberg | Buy → Hold |
| Jun-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Mar-01-21 | Initiated | Citigroup | Buy |
| Mar-01-21 | Initiated | Oppenheimer | Outperform |
| Mar-01-21 | Initiated | Piper Sandler | Overweight |
View All
Sensei Biotherapeutics Inc Stock (SNSE) Latest News
What Sparked Sensei Biotherapeutics (SNSE) Stock's Nearly 63% After‑Hours Jump? - Sahm
Major Stakeholders Offload Shares in Sensei Biotherapeutics! - TipRanks
Major Stakeholders Offload Sensei Biotherapeutics Shares! - TipRanks
Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Down 8% – What’s Next? - Defense World
Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast - ts2.tech
Sensei Biotherapeutics Inc (SNSE) looking to reclaim success with recent performance - Setenews
How Sensei Biotherapeutics Inc. (4070) stock compares with tech leadersJuly 2025 Outlook & Daily Volume Surge Signals - Newser
Can Sensei Biotherapeutics Inc. (4070) stock deliver double digit returnsWeekly Risk Summary & Capital Efficient Trading Techniques - Newser
How Sensei Biotherapeutics Inc. (4070) stock correlates with oil marketsEarnings Recap Report & Smart Money Movement Tracker - Newser
Can Sensei Biotherapeutics Inc. (4070) stock attract ESG investmentsTrade Exit Report & Low Drawdown Momentum Trade Ideas - Newser
How big funds are accumulating Sensei Biotherapeutics Inc. (4070) stockRecession Risk & Weekly High Potential Alerts - Newser
Is Sensei Biotherapeutics Inc. stock vulnerable to regulatory risksTreasury Yields & Comprehensive Market Scan Reports - BỘ NỘI VỤ
Sensei Biotherapeutics Halts Lead Drug Development, Explores Sale Or Merger Options - MSN
Will Sensei Biotherapeutics Inc. (4070) stock outperform value peersQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com
How Sensei Biotherapeutics Inc. (4070) stock reacts to new regulations2025 Investor Takeaways & Expert Verified Movement Alerts - newser.com
Can Sensei Biotherapeutics Inc. (4070) stock deliver strong annual returnsQuarterly Growth Report & AI Powered Market Entry Ideas - newser.com
Can Sensei Biotherapeutics Inc. (4070) stock survive global slowdownTrade Volume Report & Weekly Stock Breakout Alerts - newser.com
What sentiment indicators say about Sensei Biotherapeutics Inc. stockJuly 2025 Sector Moves & Daily Entry Point Trade Alerts - newser.com
Why Sensei Biotherapeutics Inc. (4070) stock attracts HNW investors2025 Market Trends & Weekly Market Pulse Updates - newser.com
Can Sensei Biotherapeutics Inc. (4070) stock ride next bull market cycleEarnings Risk Summary & Risk Controlled Swing Trade Alerts - newser.com
Will Sensei Biotherapeutics Inc. stock outperform Dow Jones indexFed Meeting & Daily Oversold Bounce Ideas - newser.com
Will Sensei Biotherapeutics Inc. (4070) stock announce a stock split2025 Growth vs Value & Free Community Supported Trade Ideas - newser.com
How Sensei Biotherapeutics Inc. stock reacts to inflationary pressuresMarket Performance Summary & Precise Swing Trade Alerts - newser.com
Is Sensei Biotherapeutics Inc. (4070) stock worth buying before Fed actionWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com
What downside risks could hit Sensei Biotherapeutics Inc. (4070) stockTrade Exit Summary & Real-Time Buy Zone Alerts - newser.com
Is Sensei Biotherapeutics Inc. stock reversal real or fakeRisk Management & Free Expert Verified Stock Movement Alerts - newser.com
What momentum indicators show for Sensei Biotherapeutics Inc. stockQuarterly Portfolio Report & Breakout Confirmation Trade Signals - newser.com
Seaport biotech lays off most of its employees amid sale talks - Boston.com
Will Sensei Biotherapeutics Inc. stock benefit from automationWeekly Risk Report & Risk Controlled Daily Plans - newser.com
Sensei Biotherapeutics Inc Stock (SNSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sensei Biotherapeutics Inc Stock (SNSE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc | 10% Owner |
Dec 09 '25 |
Sale |
8.25 |
6,612 |
54,575 |
155,142 |
| Peyer James | 10% Owner |
Dec 09 '25 |
Option Exercise |
6.40 |
395 |
2,528 |
155,983 |
| Peyer James | 10% Owner |
Dec 09 '25 |
Sale |
7.96 |
3,507 |
27,903 |
155,142 |
| Peyer James | 10% Owner |
Dec 08 '25 |
Sale |
8.59 |
3,105 |
26,672 |
158,254 |
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):